QBECO

N/A

Report date: 2026/02/24 20:00:16

Base Information

Drug NameQBECO
Drug Alias NameSite specific immunomodulator位点特异性免疫调节剂QBECOQBECO-SSI
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesQu Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSunnybrook Health Sciences CentreQu Biologics Inc
Inactive CompaniesN/A
Active IndicationsLiver NeoplasmsColorectal Neoplasms
Inactive IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A